About Us
MassMed is a name that embodies our vision, purpose, and commitment to healthcare access across the globe.
Massmed Private Limited is a globally oriented pharmaceutical company committed to delivering high-quality, affordable, and reliable healthcare solutions. Incorporated in 2018, our business is built on a unique model that integrates product development, manufacturing, regulatory expertise, global marketing, and logistics—all through a strong network of CDMOs (Contract Development and Manufacturing Organizations) with international regulatory approvals (WHO-GMP, EU-GMP, USFDA, etc.).
We specialize in pharmaceuticals, medical devices, nutraceuticals, and herbal products, serving both human and veterinary health segments. Through our subsidiaries and representative offices, we work closely with local healthcare providers, distributors, and authorities to ensure effective product registration, market penetration, and regulatory compliance.
Our Mission
To enable access to quality-assured medicines, medical devices, and wellness products worldwide through strategic partnerships, regulatory excellence, and sustainable growth.
Our Vision
To be a globally recognized healthcare solutions provider delivering value through quality, innovation, and trust. To ensure access to high-quality medications by sourcing from reputed manufacturers and adhering to international healthcare standards.
Our Core Values
Integrity
Honest and ethical practices in all operations.
Regulatory Excellence
Minimizing delays through proactive, clean dossier submissions.
Quality Focus
Offering validated, consistent, and safe healthcare products.
Customer Commitment
Solutions built around customer needs and market demand.
Innovation
Enabling product development, even for complex or niche molecules.
Global Collaboration
Building win-win partnerships with manufacturers, distributors, and regulators.
Our Journey
A visual journey of our progress since inception.
- 2018
Foundation Year
Massmed Private Limited was officially incorporated in India.
Strategic direction was set by the four founding directors with expertise in manufacturing, marketing, finance, and regulatory sciences.
- 2019
Market Entry & Expansion in CIS
Successfully registered our pharmaceutical product in Uzbekistan and Turkmenistan, marking our entry into the CIS market.
Established our first overseas representative office in Tashkent, Uzbekistan, enabling direct regulatory engagement and local operations.
- 2020
Medical Device Portfolio Expansion
Registered our medical device in Uzbekistan.
Achieved registration of seven additional pharmaceutical products in the same market.
Strengthened our product portfolio and laid the foundation for diversification.
- 2021
Entry into Herbal Segment
Launched our first herbal product in Uzbekistan, responding to regional demand for traditional therapies.
Collaborated with CDMOs for development and submission of herbal dossiers.
- 2022
Geographic Expansion into Ukraine
Amplified our commercial and regulatory activities by expanding into Ukraine.
Built relationships with local partners to strengthen our presence in the region.
Our Leadership
Mr. Anurag Borad
Director, Manufacturing & Regulatory Affairs
Leads procurement, manufacturing partnerships and regulatory documentation.
Mr. Sandeep Ranjan
Director, CIS Markets & Operations
Based in Uzbekistan. Oversees operations, medical strategy and regulatory navigation across the CIS region.
Mr. Mihir Shah
Director, Africa & Latin America Markets
Drives market entry, distribution and partnerships across African and Latin American regions.
Mr. Sanjay Kumar Singh
Director, Finance & Business Operations
Handles strategic finance, compliance and overall business administration.
